EuGeni, page-2324

We'll See now if Labor is in our corner!! Where are we at with all these tests from last qtrly...

Australian Clinical Trial

“AnteoTech will provide information on theoutcome at the conclusion of the trial and on receipt of a final report.”

https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12622000570785

“Anticipated date of last participantenrolment

15/04/2022”

I would say the trial is done and waitingon report. We are now end of May should be soon.

Spanish Clinical Trial.

The final site selection and site visits, akey step in the clinical trial process, have now been completed. At the time ofwriting, ethics protocols for each site were under review by the individualstudy sites and the CRO.

It is anticipated that patient recruitment willhave commenced at the first trial site by end April.

Spain is averaging about 15000 cases a day,hopefully won’t take too loong to get 300 participants.

EuGeni Multiplex (Combo SARS-CoV-2Influenza A/B Ag RDT)

The design of the assay was also officiallylocked in during the quarter, which was followed by bilateral visits withOperon to commence the manufacturing technology transfer process. At the end ofMarch, the initial manufacturing transfer process to Operon was completed, withthe first small batch runs to occur in April.

Target for Multiplex to market for Overseas( Hopefully by December 22)

Winter in Europe – ( Dec to Feb)

Winter in US - ( Dec 21 to Mar 21)

FDA is left left field popped up in Last Announcement that seemed to have progressed in the background - Thanks for letting us know Derek and Jack!!
Hopefully things have started to fast track in the background since the webinar from hell and the manufacturing problems sound like they have been ironed out.


Anyway it looks like a race to the finish line between batteries and life Science - my pick is battery deal will come in first.

Cheers

M.oz